Symbol
APUS on NYSE
Investment type
Equity / Common Stock
Latest Disclosed Ownership
4.39M shares
Security Ownership
37.9%

Apimeds Inc. ownership in Apimeds Pharmaceuticals US, Inc. Common Stock (APUS)

2025-05-19 - Apimeds Inc. has filed an SCHEDULE 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.39M shares of Apimeds Pharmaceuticals US, Inc. Common Stock (APUS). This represents 37.9% percent ownership of the company.